Denosumab contraindicated in patients with unhealed lesions
Denosumab (Xgeva, Prolia; Amgen) 120mg is now contraindicated in patients with unhealed lesions from dental or oral surgery. More information is available from the Medicines and Healthcare products Regulatory Agency website.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069048
Recommended from Pharmaceutical Press